DocuSign Valuation
Is DOCU * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DOCU * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DOCU * (MX$1215) is trading below our estimate of fair value (MX$1975.22)
Significantly Below Fair Value: DOCU * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DOCU *?
Other financial metrics that can be useful for relative valuation.
What is DOCU *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$12.69b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.2x |
Enterprise Value/EBITDA | 62.3x |
PEG Ratio | -0.3x |
Price to Earnings Ratio vs Peers
How does DOCU *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 50.6x | ||
NEM Nemetschek | 62.2x | 17.0% | €11.0b |
688111 Beijing Kingsoft Office Software | 71.3x | 18.9% | CN¥102.7b |
532466 Oracle Financial Services Software | 42.3x | 11.7% | ₹988.1b |
NICE NICE | 26.7x | 14.9% | ₪39.5b |
DOCU * DocuSign | 12.7x | -46.3% | Mex$12.7b |
Price-To-Earnings vs Peers: DOCU * is good value based on its Price-To-Earnings Ratio (12.7x) compared to the peer average (50.7x).
Price to Earnings Ratio vs Industry
How does DOCU *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Earnings vs Industry: DOCU * is good value based on its Price-To-Earnings Ratio (12.7x) compared to the Global Software industry average (31x).
Price to Earnings Ratio vs Fair Ratio
What is DOCU *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 12.7x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DOCU *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,215.00 | Mex$1,271.39 +4.6% | 16.0% | Mex$1,707.22 | Mex$981.16 | n/a | 17 |
Sep ’25 | Mex$1,200.00 | Mex$1,110.56 -7.5% | 17.5% | Mex$1,540.55 | Mex$859.84 | n/a | 18 |
Aug ’25 | Mex$1,017.41 | Mex$1,110.56 +9.2% | 17.5% | Mex$1,540.55 | Mex$859.84 | n/a | 18 |
Jul ’25 | Mex$1,002.00 | Mex$1,171.18 +16.9% | 17.1% | Mex$1,613.68 | Mex$900.66 | n/a | 19 |
Jun ’25 | Mex$915.70 | Mex$1,109.16 +21.1% | 16.9% | Mex$1,580.64 | Mex$815.81 | n/a | 19 |
May ’25 | Mex$950.00 | Mex$1,094.49 +15.2% | 17.2% | Mex$1,548.89 | Mex$799.43 | n/a | 20 |
Apr ’25 | Mex$1,017.00 | Mex$1,089.33 +7.1% | 18.3% | Mex$1,556.27 | Mex$803.24 | n/a | 20 |
Mar ’25 | Mex$935.00 | Mex$1,023.58 +9.5% | 22.0% | Mex$1,534.31 | Mex$750.11 | n/a | 20 |
Feb ’25 | Mex$1,065.00 | Mex$1,049.15 -1.5% | 21.2% | Mex$1,549.41 | Mex$757.49 | n/a | 20 |
Jan ’25 | Mex$1,010.00 | Mex$1,008.08 -0.2% | 22.5% | Mex$1,543.73 | Mex$754.71 | n/a | 20 |
Dec ’24 | Mex$767.00 | Mex$1,108.26 +44.5% | 21.3% | Mex$1,568.59 | Mex$721.19 | n/a | 19 |
Nov ’24 | Mex$700.00 | Mex$1,108.26 +58.3% | 21.3% | Mex$1,568.59 | Mex$721.19 | n/a | 19 |
Oct ’24 | Mex$732.00 | Mex$1,095.26 +49.6% | 20.1% | Mex$1,538.46 | Mex$742.71 | n/a | 19 |
Sep ’24 | Mex$870.00 | Mex$1,110.99 +27.7% | 17.6% | Mex$1,432.31 | Mex$750.26 | Mex$1,200.00 | 18 |
Aug ’24 | n/a | Mex$1,122.12 0% | 16.4% | Mex$1,434.43 | Mex$819.67 | Mex$1,017.41 | 18 |
Jul ’24 | Mex$873.97 | Mex$1,122.12 +28.4% | 16.4% | Mex$1,434.43 | Mex$819.67 | Mex$1,002.00 | 18 |
Jun ’24 | Mex$1,013.28 | Mex$1,167.63 +15.2% | 18.8% | Mex$1,591.96 | Mex$795.98 | Mex$915.70 | 18 |
May ’24 | Mex$886.00 | Mex$1,238.98 +39.8% | 17.9% | Mex$1,665.48 | Mex$888.25 | Mex$950.00 | 17 |
Apr ’24 | Mex$1,033.00 | Mex$1,238.98 +19.9% | 17.9% | Mex$1,665.48 | Mex$888.25 | Mex$1,017.00 | 17 |
Mar ’24 | Mex$1,125.00 | Mex$1,181.01 +5.0% | 18.7% | Mex$1,652.90 | Mex$881.54 | Mex$935.00 | 17 |
Feb ’24 | Mex$1,144.00 | Mex$1,171.62 +2.4% | 20.8% | Mex$1,688.34 | Mex$712.85 | Mex$1,065.00 | 18 |
Jan ’24 | Mex$1,013.72 | Mex$1,173.84 +15.8% | 23.2% | Mex$1,757.99 | Mex$742.26 | Mex$1,010.00 | 18 |
Dec ’23 | Mex$900.00 | Mex$1,292.12 +43.6% | 23.2% | Mex$1,793.98 | Mex$848.76 | Mex$767.00 | 18 |
Nov ’23 | Mex$947.00 | Mex$1,370.35 +44.7% | 21.4% | Mex$1,858.56 | Mex$879.32 | Mex$700.00 | 17 |
Oct ’23 | Mex$1,099.00 | Mex$1,421.28 +29.3% | 18.1% | Mex$1,871.44 | Mex$1,066.52 | Mex$732.00 | 17 |
Sep ’23 | Mex$1,220.00 | Mex$1,502.39 +23.1% | 31.9% | Mex$3,041.28 | Mex$1,007.05 | Mex$870.00 | 16 |
Analyst Forecast: Target price is less than 20% higher than the current share price.